RESUMEN
The expression of different members of the Jun and Fos families of transcription factors is rapidly induced following serum stimulation of quiescent fibroblasts. To determine whether these proteins are required for cell cycle progression, we microinjected affinity-purified antibodies directed against c-Fos, FosB, Fra-1, c-Jun, JunB, and JunD, and antibodies that recognize either the Fos or the Jun family of proteins, into Swiss 3T3 cells and determined their effects in cell cycle progression by monitoring DNA synthesis. We found that microinjection of anti-Fos and anti-Jun family antibodies efficiently blocked the entrance to the S phase of serum-stimulated or asynchronously growing cells. However, the antibodies against single members of the Fos family only partially inhibited DNA synthesis. In contrast, all three Jun antibodies prevented DNA synthesis more effectively than did any of the anti-Fos antibodies.
Asunto(s)
Ciclo Celular , Proteínas de Unión al ADN/fisiología , Fibroblastos/citología , Proteínas Proto-Oncogénicas/fisiología , Factores de Transcripción/fisiología , Animales , Anticuerpos/inmunología , Especificidad de Anticuerpos , División Celular , Línea Celular , ADN/biosíntesis , Proteínas de Unión al ADN/inmunología , Técnica del Anticuerpo Fluorescente , Ratones , Microinyecciones , Pruebas de Precipitina , Proteínas Proto-Oncogénicas/inmunología , Proteínas Proto-Oncogénicas c-fos , Proteínas Proto-Oncogénicas c-jun , Factores de Transcripción/inmunologíaRESUMEN
We have characterized the expression of c-Jun, JunB, JunD, c-Fos, and FosB proteins following serum stimulation of quiescent Swiss 3T3 cells by immunoprecipitation analyses. The synthesis of the three Jun proteins rapidly increases following stimulation, remaining at a significant level for at least 8 h. JunB protein presents the highest expression of all. FosB, like c-Fos, is transiently induced. Pulse-chase experiments show that all of the proteins except JunD are short-lived. We have shown that c-Fos and FosB form complexes in vivo with the different Jun proteins and that JunB complexes are predominant. In vitro association and competition experiments show that the affinities between the different Fos and Jun proteins are similar. This finding, together with the in vivo observations described above, suggests that the proportion of the different Jun/Fos heterodimers is governed by the concentration of the different components. The Fos and Jun proteins are phosphoproteins, and some remain relatively highly phosphorylated in their heterodimeric form.
Asunto(s)
Proteínas de Unión al ADN/genética , Fase G1 , Proteínas Proto-Oncogénicas/genética , Fase de Descanso del Ciclo Celular , Factores de Transcripción/genética , Animales , Anticuerpos , Línea Celular , Proteínas de Unión al ADN/biosíntesis , Proteínas de Unión al ADN/aislamiento & purificación , Fibroblastos/citología , Fibroblastos/enzimología , Inmunoensayo , Cinética , Ratones , Plásmidos , Unión Proteica , Biosíntesis de Proteínas , Proteínas Tirosina Quinasas/genética , Proteínas Proto-Oncogénicas/biosíntesis , Proteínas Proto-Oncogénicas/aislamiento & purificación , Proteínas Proto-Oncogénicas c-fos , Proteínas Proto-Oncogénicas c-jun , Procesamiento Postranscripcional del ARN , Factores de Transcripción/biosíntesis , Factores de Transcripción/aislamiento & purificaciónRESUMEN
We have determined the different Fos/Jun complexes present in Swiss 3T3 cells either following serum stimulation of quiescent cells or during exponential growth by immunoprecipitation analyses. We have shown that while c-Fos is the major Fos protein associated with the Jun proteins (c-Jun, JunB, and JunD) soon after serum stimulation, at later times Fra-1 and Fra-2 are the predominant Fos proteins associated with the different Jun proteins. During exponential growth, the synthesis of Fra-1 and Fra-2 is maintained at a significant level, in contrast to c-Fos and FosB, which are expressed at very low or undetectable levels. Consequently, Fra-1 and Fra-2 are the main Fos proteins complexed with the Jun proteins in asynchronously growing cells. To determine whether the Fos proteins are differentially required during the G0-to-G1 transition and exponential growth for the entrance into S phase, we microinjected affinity-purified antibodies directed against c-Fos, FosB, Fra-1, and Fra-2. We have found that while the activities of c-Fos and FosB are required mostly during the G0-to-G1 transition, Fra-1 and Fra-2 are involved both in the G0-to-G1 transition and in asynchronous growth.
Asunto(s)
División Celular , Fase G1 , Proteínas Proto-Oncogénicas c-fos/metabolismo , Proteínas Proto-Oncogénicas c-jun/metabolismo , Fase de Descanso del Ciclo Celular , Células 3T3 , Animales , Fibroblastos/citología , Cinética , Ratones , Fase SRESUMEN
We demonstrate that a member of the fos family, the fosB gene, gives rise to two transcripts by alternative splicing of exon 4, generating two proteins, FosB of 338 amino acids and a short form, FosB/SF, which contains the DNA binding and dimerization domains but not the 101 amino acids of the C terminus. FosB/SF activates an AP-1-chloramphenicol acetyltransferase construct in NIH 3T3 cells, as determined by transient and stable transfections, although more weakly than does FosB. In contrast to FosB, FosB/SF has lost its ability to repress the dyad symmetry element of the c-fos gene. FosB/SF when expressed in excess to FosB can downmodulate the activity of FosB. Constitutive expression of high levels of FosB/SF in NIH 3T3 cells has no significant inhibitory effect in the induction of cell proliferation or cell cycle progression, indicating that FosB/SF is not a negative regulator of cell growth. This conclusion is further confirmed by the observation that the majority of the Jun molecules are complexed with FosB/SF in the FosB/SF-overexpressing cells.
Asunto(s)
Exones , Genes fos , Proteínas Proto-Oncogénicas c-fos/genética , Empalme del ARN , Transactivadores/genética , Transfección , Células 3T3 , Animales , Secuencia de Bases , División Celular , Cloranfenicol O-Acetiltransferasa/genética , Cloranfenicol O-Acetiltransferasa/metabolismo , Fibroblastos/citología , Fibroblastos/fisiología , Vectores Genéticos , Ratones , Datos de Secuencia Molecular , Oligonucleótidos , Plásmidos , Reacción en Cadena de la Polimerasa , Biosíntesis de Proteínas , Transcripción Genética , Activación TranscripcionalRESUMEN
Activation of T cells induces transcription of the interleukin-2 (IL-2) gene. IL-2 expression is regulated through the binding of transcription factors to multiple sites within the IL-2 enhancer. One such cis-acting element within the IL-2 enhancer is the NFAT-1 (nuclear factor of activated T cells) binding site. NFAT-1 binding activity is absent in resting cells but is induced upon T-cell activation. The induction of NFAT-1 binding activity can be inhibited by cyclosporin A, potentially accounting for the ability of cyclosporin A to inhibit IL-2 production by T cells. We have previously reported that the NFAT-1 binding complex is composed of at least two proteins and that the 5' portion of the NFAT-1 sequence acts as a binding site for one or more proteins from the Ets family of transcription factors. We now report that the 3' portion of the NFAT-1 sequence contains a variant AP-1 binding site. NFAT-1 binding can be specifically inhibited by oligonucleotides containing a consensus AP-1 site. Moreover, mutation of the AP-1 site at the 3' end of the NFAT-1 sequence inhibits both NFAT-1 binding and the ability of the NFAT-1 binding site to activate expression from a reporter plasmid upon T-cell activation. Since AP-1 sites bind dimeric protein complexes composed of individual members of the Fos and Jun families of transcription factors, we used antibodies specific for individual Fos and Jun family members to determine whether they are present in the NFAT-1 binding complex. These experiments demonstrated that the NFAT-1 binding complex contains JunB and Fra-1 proteins. Northern (RNA) blot analyses demonstrate that both fra-1 and junB mRNAs are induced upon T-cell activation, although fra-1 mRNA is present even in quiescent T cells. Of interest, junB is not expressed in quiescent T cells, and it is induced with kinetics that are similar to those for the induction of IL-2 mRNA expression. Taken together, these results suggested that the JunB-Fra-1 heterodimer is the inducible nuclear component of the NFAT-1 binding activity and that JunB expression regulates the formation of the heterodimer. In addition, these data indicated that specific heterodimers of Fos and Jun family members may have selective roles in the induction of transcription during cellular activation.
Asunto(s)
Elementos de Facilitación Genéticos/genética , Interleucina-2/metabolismo , Activación de Linfocitos , Proteínas Proto-Oncogénicas c-jun/metabolismo , Linfocitos T/metabolismo , Sustancias Macromoleculares , Proteínas Recombinantes/biosíntesis , Transcripción Genética , beta-Galactosidasa/genéticaRESUMEN
fos B encodes a nuclear protein with 70% homology to c-fos, whose expression is transiently induced during the G0/G1 transition. Immunoprecipitation studies demonstrated that FOS B protein forms a complex in vitro with c-JUN, JUN B, and JUN D. We have mutated some of the leucines of the 'leucine zipper' present in the FOS B protein and determined their effect in the interaction with JUN proteins and their binding to an AP-1 containing sequence. The exchange of either leucine 1, 3, or 5 of the leucine repeat of FOS B to a proline dramatically inhibits its association with JUN proteins. However, a more conserved substitution to isoleucine has only a 50% inhibition. These results demonstrate that any major alteration in the alpha-helical structure of the 'leucine zipper' completely inhibits the interaction of FOS B with any of the three JUN proteins.
Asunto(s)
Proteínas de Unión al ADN/fisiología , Proteínas Nucleares/fisiología , Proteínas Proto-Oncogénicas/fisiología , Factores de Transcripción/fisiología , Secuencia de Aminoácidos , Secuencia de Bases , Análisis Mutacional de ADN , Técnicas In Vitro , Sustancias Macromoleculares , Datos de Secuencia Molecular , Proteínas Nucleares/ultraestructura , Unión Proteica , Proteínas Proto-Oncogénicas/ultraestructura , Proteínas Proto-Oncogénicas c-fos , Proteínas Proto-Oncogénicas c-jun , Secuencias Reguladoras de Ácidos Nucleicos , Relación Estructura-Actividad , Factores de Transcripción/ultraestructuraRESUMEN
The Fos family of transcription factors, c-Fos, FosB, Fra-1 and Fra-2, are rapidly induced in quiescent fibroblasts following serum or growth factor stimulation. The Fos proteins show distinct patterns of expression during cell growth with only Fra-1 and Fra-2 maintained at significant levels in growing cells, suggesting that the different family members direct unique functions for cell growth. Post-translational modification of Fos proteins has been observed following serum stimulation, which may allow an additional level of regulation. Our studies show that the synthesis and post-translational modification of Fra-1 and Fra-2 in Swiss 3T3 cells is serum-dependent during G1 following the transition from G0 and during asynchronous growth but is serum-independent during S phase and mitosis. Post-translational modification of Fra-1 and Fra-2 causes a significant shift in their gel mobility which is eliminated by alkaline phosphatase treatment. Several kinases can phosphorylate Fra-1 and Fra-2 in vitro, including cAMP-dependent kinase (PKA), protein kinase C (PKC), cyclin-dependent kinase 1-cdc2 (cdc2), and mitogen activated protein (MAP) kinase. From these, MAP kinase is the only one that causes a shift in gel mobility similar to that observed in vivo. One dimensional phosphopeptide maps of Fra-1 and Fra-2 phosphorylated by MAP kinase in vitro are similar to those of in vivo labeled Fra-1 and Fra-2, suggesting that MAP kinase may also phosphorylate Fra-1 and Fra-2 in vivo. We have also determined that phosphorylation of Fra-1 and Fra-2 by MAP kinase increases their DNA binding activity.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , ADN/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Factores de Transcripción/metabolismo , Células 3T3 , Animales , Secuencia de Bases , Fenómenos Fisiológicos Sanguíneos , Proteínas Quinasas Dependientes de Calcio-Calmodulina/fisiología , Ciclo Celular , Proteínas Quinasas Dependientes de AMP Cíclico/fisiología , Antígeno 2 Relacionado con Fos , Ratones , Datos de Secuencia Molecular , Fosforilación , Proteína Quinasa C/fisiología , Procesamiento Proteico-PostraduccionalRESUMEN
We present the first comparative investigation of the basal and transsynaptically induced expression of c-JUN, JUN B, JUN D, c-FOS, FOS B, and KROX-24 proteins in the spinal cord, using immunocytochemistry with specific antibodies. We demonstrate that electrical stimulation of the sciatic nerve at A delta/C-fiber (not A alpha/beta-fiber) intensity strongly induces the expression of these immediate-early gene-encoded proteins. Basal immunoreactivity was found for c-JUN in motoneurons, for JUN D in almost every cell of the gray matter, and for KROX-24 in the superficial dorsal horn. One hour after electrical stimulation of the sciatic nerve at A delta/C-fiber intensity, expression of all proteins except JUN D reached its maximum. Initially immunoreactivity was restricted to the ipsilateral dorsal horn, but after 4 hours appeared contralaterally. Expression of JUN D was increased only after 4 hours. Within the dorsal horn, the expression of c-JUN, JUN B, FOS B, and KROX-24 was mainly restricted to the superficial layers. Immunoreactivity decreased to basal levels between 8 and 16 hours. c-FOS and JUN D were expressed in both the superficial and deep dorsal horn; in the latter, c-FOS and JUN D persisted longer. Induced JUN D was present the longest and was still visible after 32 hours. In motoneurons of the ipsilateral ventral horn, c-JUN, JUN D, and c-FOS appeared after 8 hours. Surgical exposure of the sciatic nerve evoked a strikingly prolonged expression of all proteins compared to that following electrical stimulation of the sciatic nerve. Our results demonstrate that stimulation of nociceptive A delta- and C-fibers induces early and late expression of proteins encoded by immediate-early genes with a specific temporal and spatial distribution of the expression of each protein. Furthermore, the extent of protein expression reflects the intensity of noxious stimulation.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Proteínas Inmediatas-Precoces , Neuronas/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Proteínas Proto-Oncogénicas c-jun/metabolismo , Médula Espinal/metabolismo , Sinapsis/fisiología , Factores de Transcripción/metabolismo , Animales , Proteína 1 de la Respuesta de Crecimiento Precoz , Estimulación Eléctrica , Regulación de la Expresión Génica , Inmunohistoquímica , Masculino , Fibras Nerviosas/fisiología , Fibras Nerviosas Mielínicas/fisiología , Neuronas/fisiología , Ratas , Ratas Endogámicas , Nervio Ciático/fisiología , Médula Espinal/citología , Médula Espinal/fisiología , Factores de TiempoRESUMEN
Jun, Fos, and Krox proteins are inducible transcription factors contributing to the control of gene expression. The elucidation of their individual expression patterns in the nervous system provides new insights into the ability of neurons to react with changes of gene expression to external stimulation under physiological or pathological conditions. The expression of c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 was investigated in the brain of untreated male Sprague-Dawley and female BDIX rats by immunocytochemistry using specific antibodies. JunD immunoreactivity (IR) labeled the highest number of neurons, being present in almost all neurons of the brain. JunD was expressed at high levels in those areas that also exhibit c-Jun, JunB, c-Fos, and FosB-IR, such as locus coeruleus, periolivary nuclei (ncl.), pontine and central gray, lateral lemniscal ncl., inferior and superior colliculi, leaflet of geniculate ncl., midline nuclei of thalamus, dorsomedial and paraventricular ncl. of hypothalamus, ncl. supraopticus, dorsolateral part of caudate putamen and lateral septal ncl. In contrast to the high number of JunD-positive neurons, c-Jun, JunB, c-Fos, and FosB proteins were detected in rather low numbers of neurons in these brain areas; the rank of the number of immunopositive neurons was c-Fos > JunB > c-Jun > FosB. Particularly high levels of expression were observed for c-Jun in medullary motoneurons, medial geniculate ncl., arcuate ncl., and dentate gyrus, and for JunB in the CA-1 area of the hippocampus and islands of Calleja. The zinc finger protein Krox-24 was expressed in many neurons of these brain areas, with only discrete Jun- and Fos-IR; additionally, many intensely labeled nuclei were present in spinal ncl. of the trigeminal ventromedial ncl. of the hypothalamus and the CA-1 area of the hippocampus. In the cerebellum, nuclear labeling was detected only for c-Jun, JunD, and Krox-24 in granule cells. JunD-IR was also found in glial cells of gray matter and fiber tracts, whereas glial c-Jun-IR was observed only in fiber tracts. Apart from a weak JunD-IR, some areas did not express Jun, Fos, and Krox proteins such as cuneate and gracile ncl., venterobasal complex of thalamus, globus pallidum, and Purkinje cells of the cerebellum. Our data indicate that inducible transcription factors of the fos, jun, and krox gene families show patterns of individual expression in untreated animals, thereby reflecting different mechanisms and/or thresholds for induction under physiological conditions.
Asunto(s)
Encéfalo/metabolismo , Proteínas Inmediatas-Precoces , Proteínas del Tejido Nervioso/biosíntesis , Factores de Transcripción/biosíntesis , Animales , Metabolismo Basal , Encéfalo/citología , Proteínas de Unión al ADN/biosíntesis , Proteína 1 de la Respuesta de Crecimiento Precoz , Femenino , Masculino , Neuroglía/metabolismo , Neuronas/metabolismo , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Proteínas Proto-Oncogénicas c-jun/biosíntesis , Ratas , Ratas Endogámicas , Ratas Sprague-Dawley , Especificidad de la Especie , Dedos de Zinc/fisiologíaRESUMEN
Toxicity of an aqueous extract prepared from Echinodorus macrophyllus dried leaves, a plant used in folk medicine to treat inflammation and kidney malfunctions, was estimated by different bioassays. Mutagenicity of the aqueous extract was evaluated in the Salmonella/microsome assay (TA97a, TA98, TA100 and TA102 strains), with or without metabolic activation. No mutagenic activity (lyophilized extract tested up to 50 mg/plate) could be detected to any of the tester strain. Furthermore, no cytotoxic effect has been observed when a crude extract of E. macrophyllus (up to 7.5 mg/ml) was tested on the exponential growth of hepatoma and normal kidney epithelial cells in culture. Toxicity of E. macrophyllus was also evaluated in male Swiss mice after 6 weeks of continuous ingestion of the aqueous extract in drinking water. Average daily ingested doses were 3, 23 and 297 mg/kg for a lyophilized extract, and 2200 mg/kg for a crude extract, with dose two being equivalent to the daily dose recommended to humans. At the end of the treatment, all animals revealed a deficit in final body weight ranging from 5 to 47%. Biochemical analysis of the plasma revealed some minor alterations indicating subclinical hepatic toxicity. Genotoxic effect on liver, kidney and blood cells has been also evaluated by the comet assay, being negative to liver and blood cells. However, DNA analyses of the kidney cells detected some genotoxic activity for the highest dose tested of E. macrophyllus extract, either lyophilized or crude. On the other hand, exposure dose of 23 mg/kg, equivalent to the daily dose recommended to humans, did not revealed any genotoxic effect and hence this herb seems to be safe to human organism.
Asunto(s)
Plantas Medicinales , Animales , Peso Corporal/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , Masculino , Ratones , Pruebas de Mutagenicidad , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/toxicidad , Ratas , Células Tumorales CultivadasRESUMEN
Cumulative evidence suggests that moderate wine consumption exerts a cardioprotective effect. We investigated the occurrence of an antihypertensive effect of an alcohol-free hydroalcoholic grape skin extract (GSE) obtained from skins of a vinifera grape (Vitis labrusca) in experimental rodent hypertension models. The vasodilator effect of GSE (polyphenols concentration 55.5 mg g(-1)) was also assessed in the isolated mesenteric vascular bed of Wistar rats and the antioxidant effect was studied on lipid peroxidation of hepatic microsomes. Oral administration of GSE significantly reduced systolic, mean and diastolic arterial pressure in Wistar rats with desoxycorticosterone acetate-salt and N(G)-nitro-L-arginine methyl ester (L-NAME) induced experimental hypertension. In the rat isolated mesenteric vascular bed pre-contracted with norepinephrine, bolus injections of GSE induced endothelium-dependent vasodilatation that was substantially inhibited by L-NAME, but not by indometacin, tetraethylammonium or glibenclamide. Lipid peroxidation of hepatic microsomes estimated as malondialdehyde production was concentration-dependently inhibited by GSE. In conclusion, the antihypertensive effect of GSE might be owing to a combination of vasodilator and antioxidant actions of GSE. These findings also suggest that the beneficial effect of moderate red wine consumption could be owing to an antihypertensive action induced by compounds occurring in the skin of vinifera grapes.
Asunto(s)
Antihipertensivos/uso terapéutico , Antioxidantes/uso terapéutico , Flavonoides , Hipertensión/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Vasodilatadores/uso terapéutico , Vitis/química , Animales , Antihipertensivos/farmacología , Antioxidantes/farmacología , Hipertensión/inducido químicamente , Hipertensión/fisiopatología , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Masculino , Arteria Mesentérica Superior/efectos de los fármacos , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo , Fenoles/análisis , Extractos Vegetales/química , Polímeros/análisis , Polifenoles , Ratas , Ratas Wistar , Factores de Tiempo , Vasodilatación/efectos de los fármacos , Vasodilatadores/farmacología , Agua , VinoRESUMEN
1. Peptide growth factors and products of some oncogenes are likely to be active in common regulatory pathways that control the cell cycle. 2. Cell transformation by DNA-mediated transfections with cloned oncogenes is an approach that can provide insight into the mechanisms of both growth factor action and cell cycle regulation. 3. This paper deals with this approach, summarizing and discussing transfection experiments of mouse c-myc and human c-Ha-ras-1 cloned oncogenes into mouse embryo Balb-3T3 cells.
Asunto(s)
Transformación Celular Neoplásica/efectos de los fármacos , Sustancias de Crecimiento/farmacología , Oncogenes/efectos de los fármacos , Animales , Ciclo Celular/efectos de los fármacos , Línea Celular , Células Cultivadas , Embrión de Mamíferos/citología , Humanos , Ratones , Ratones Endogámicos BALB CAsunto(s)
Anticuerpos/administración & dosificación , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Proteínas Proto-Oncogénicas c-jun/biosíntesis , Proteínas Proto-Oncogénicas/biosíntesis , Células 3T3 , Animales , Anticuerpos/aislamiento & purificación , Cromatografía de Afinidad/métodos , Clonación Molecular/métodos , Reacciones Cruzadas , ADN Complementario , Indicadores y Reactivos , Ratones , Microinyecciones/métodos , Plásmidos , Biosíntesis de Proteínas , Proteínas Proto-Oncogénicas/análisis , Proteínas Proto-Oncogénicas c-fos/análisis , Proteínas Proto-Oncogénicas c-jun/análisis , Conejos/inmunología , Proteínas Recombinantes de Fusión/análisis , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/inmunología , Transfección/métodosRESUMEN
The involvement of reactive oxygen species (ROS) in the induction of DNA damage to Escherichia coli cells caused by UVC (254 nm) irradiation was studied. We verified the expression of the soxS gene induced by UVC (254 nm) and its inhibition by sodium azide, a singlet oxygen (1O2) scavenger. Additional results showed that a water-soluble carotenoid (norbixin) protects against the lethal effects of UVC. These results suggest that UVC radiation can also cause ROS-mediated lethality.
Asunto(s)
Escherichia coli/metabolismo , Escherichia coli/efectos de la radiación , Especies Reactivas de Oxígeno , Fenómenos Fisiológicos Bacterianos , Proteínas Bacterianas/química , Carotenoides/química , Carotenoides/farmacología , Relación Dosis-Respuesta en la Radiación , Proteínas de Escherichia coli/química , Depuradores de Radicales Libres/química , Radicales Libres , Oxígeno/química , Azida Sódica/química , Azida Sódica/farmacología , Transactivadores/química , Factores de Transcripción/química , Rayos Ultravioleta , Agua/químicaRESUMEN
EJ-A is a Balb-3T3 transfectant cell line that bears a small number of EJ-ras oncogene copies/cell, has low EJ-ras expression, and resembles the parental cell line in displaying a non-transformed phenotype. The glucocorticoid hormone dexamethasone reversibly induces transformation traits in EJ-A cells, namely: 1) morphological transformation; 2) increased growth rate and saturation density; 3) reduced G1 length; and 4) independence of the FGF requirement to initiate DNA synthesis. Western blot analysis revealed that dexamethasone does not increase the p21ras protein intracellular level. beta-IFN, added to the culture medium, does not suppress the dexamethasone-induced growth stimulation and morphological transformation. Therefore, glucocorticoid hormones can complement low EJ-ras expression to transform Balb-3T3 cells, by a mechanism that is likely to be independent of p21ras increase and beta-IFN decrease.
Asunto(s)
Dexametasona/farmacología , Genes ras/fisiología , Transformación Genética/efectos de los fármacos , Animales , Línea Celular Transformada , Transformación Celular Neoplásica , Cocarcinogénesis , ADN/biosíntesis , Relación Dosis-Respuesta a Droga , Factor de Crecimiento Epidérmico/farmacología , Factores de Crecimiento de Fibroblastos/farmacología , Insulina/farmacología , Interferón Tipo I/farmacología , Ratones , Ratones Endogámicos BALB C , Proteína Oncogénica p21(ras)/análisis , TransfecciónRESUMEN
The effect of EJ-ras oncogene dosage on the phenotype of Balb/3T3 transfectants was analyzed with respect to: a) peptide growth factors' requirement; b) relaxation of cell cycle control; c) tumorigenic potential. Mouse embryo-derived Balb/3T3 cells were transfected with the mutated form of the human c-Ha-ras-1 (EJ-ras) along with a genetic marker (neo gene). Transfectants displaying high EJ-ras expression presented a relaxed cell cycle control, required only insulin to initiate DNA synthesis and were highly tumorigenic. On the other hand, low expression EJ-ras transfectants required both competence (FGF) and progression factors (EGF and insulin) exactly like the parental cells. But, upon serial cultivation, these transfectants became fully transformed and highly tumorigenic without EJ-ras amplification and/or overexpression. Therefore, low EJ-ras expression primes the cells to become tumorigenic but neither overrides the cells' requirement for competence growth factor nor deregulates the cell cycle.
Asunto(s)
Genes ras , Sustancias de Crecimiento/fisiología , Neoplasias Experimentales/etiología , Transfección , Animales , Línea Celular Transformada , ADN/biosíntesis , Interfase , Ratones , Ratones Endogámicos BALB C , FenotipoRESUMEN
In the present study, we used the fetal organ culture (FTOC) technique in order to study a putative effect of epidermal growth factor (EGF) on the thymus ontogeny. Functional EGF receptors and more recently the EGF molecule itself, respectively, on the membrane of epithelial components of thymic stroma and on a few thymocytes in adult thymus, had been reported in the literature. We could observe a dose-dependent decrease in cellularity and a progressive retention of thymocytes in the double-negative (CD4-/CD8-) stage of differentiation when exogenous EGF was added. Epidermal growth factor interfered with both fetal stroma growth and thymocyte development at a precise moment, that is, in the passage from double-negative to the double-positive (CD4+/CD8+) stage. After a 7-day FTOC in the presence of EGF, most cells recovered were Thy-1.2+, c-kit+, TSA1-/int, CD3-, and one of CD44high/CD25int, CD44-/CD25int, or CD44/CD25-. Some developed into gammadeltaTCR+ cells with a mature (CD3+) phenotype, but not into alphabetaTCR+ thymocytes. It seems that EGF addition makes the cultures "nonpermissible" for alphabetaTCR+ thymocyte generation. We report here the presence of a high Mr "EGF-like" molecule on the membrane of fetal thymocytes, which role in the observed effects is under investigation. Further biochemical characterization of this molecule is still required, because its presence was only evidenced on the basis of its antigenicity.
Asunto(s)
Diferenciación Celular/efectos de los fármacos , Factor de Crecimiento Epidérmico/farmacología , Linfocitos T/citología , Timo/citología , Timo/embriología , Animales , Western Blotting , Electroforesis en Gel de Poliacrilamida , Femenino , Citometría de Flujo , Inmunohistoquímica , Ratones , Ratones Endogámicos C57BL , Técnicas de Cultivo de Órganos , Embarazo , Linfocitos T/inmunologíaRESUMEN
We have established Rat-1A cell lines constitutively expressing c-Fos and the two products of the fosB gene, FosB and its short form, FosB/SF. The expressed proteins in the different stable transfectants have been characterized by immunofluorescence and immunoprecipitation analysis. Our results demonstrate that constitutive expression of FosB, like the constitutive expression of c-Fos and, to a lesser extent, FosB/SF, results in cells that grow to increased saturation densities and have the ability to grow in an anchorage-independent manner. Most important is the finding that expression of these proteins augments the tumorigenic potential of Rat-1A cells. These results show that both forms of FosB have a stimulatory effect on cell proliferation.
Asunto(s)
Transformación Celular Neoplásica/genética , Regulación Neoplásica de la Expresión Génica , Proteínas Proto-Oncogénicas/metabolismo , Proto-Oncogenes , Transfección , Animales , División Celular , Línea Celular , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Ratas , Ensayo de Tumor de Célula MadreRESUMEN
Proteins from plasmatic membrane of ascites and solid 20-methylcholantrene induced tumours cells in inbred mice and rats were obtained by isolation of vesicles of tumor cell membranes produced in glycerol solution. The tumour cells were not broken. In a syngeneic system the inoculation of the prepared protein with adjuvant resulted in protection of 50 to 100% of animals against challenge with a syngeneic tumour cells. The same results were obtained with Ehrlich ascites tumour. The lymphocyte cytotoxicity and blastic transformation of lymphocytes in immunized animals suggested a cellular cytotoxic immunity mediated by tumour specific antigen or perhaps by fetal antigen.
Asunto(s)
Citotoxicidad Celular Dependiente de Anticuerpos , Inmunidad Celular , Neoplasias Experimentales/inmunología , Animales , Antígenos de Neoplasias , Carcinoma de Ehrlich/inducido químicamente , Membrana Celular/inmunología , Activación de Linfocitos/efectos de los fármacos , Metilcolantreno , Ratones , Ratones Endogámicos , Proteínas de Neoplasias/inmunología , Ratas , Ratas EndogámicasRESUMEN
The product of the trk proto-oncogene encodes a receptor for nerve growth factor (NGF). Here we show that NGF is a powerful mitogen that can induce resting NIH 3T3 cells to enter S phase, grow in semisolid medium, and become morphologically transformed. These mitogenic effects are absolutely dependent on expression of gp140trk receptors, but do not require the presence of the previously described low affinity NGF receptor. gp140trk also serves as a receptor for the related factor neurotrophin-3 (NT-3), but not for brain-derived neurotrophic factor. Both NGF and NT-3 induce the rapid phosphorylation of gp140trk receptors and the transient expression of c-Fos proteins. However, NT-3 appears to elicit more limited mitogenic responses than NGF. These results indicate that the product of the trk proto-oncogene is sufficient to mediate signal transduction processes induced by NGF and NT-3, at least in proliferating cells.